IT Security Risk and Compliance Analyst II

In this role, you’ll collaborate closely with cross-functional teams to design, implement, and optimize creative and cutting-edge IT security, risk, and compliance programs. You’ll be pivotal in driving security initiatives forward-coordinating, tracking, and reporting on key efforts to ensure alignment with our risk strategy and compliance goals. If you’re passionate about impacting cybersecurity while working on innovative solutions, this is your opportunity! Join a dynamic team dedicated to securing the future of United Therapeutics.

• Support the organization’s Information Security, Risk and Compliance programs (e.g., Vulnerability Management Program) to effectively address information technology risks in alignment with the organization’s risk appetite and to meet compliance requirements

• Serve as a consultant to the organization to ensure understanding of and adherence to existing security, risk, and compliance principles and requirements

• Develop and analyze reports and alerts to identify gaps and propose changes to improve the organization’s security, risk and compliance posture

• Evaluate existing and proposed technology solutions and provide recommendations and guidance to ensure business and security needs are adequately met

• Participate in risk assessments, perform risk analysis, and partner with stakeholders to create treatment plans that achieve an acceptable level of risk

• Participate in cross-functional teams, including third parties, in security, risk and compliance initiatives and driving them through to completion

• Partner with other IT teams to successfully achieve organizational goals and objectives

• Participate in incident response activities for all potential and declared IT security incidents and conduct root cause analysis and lessons learned reviews to ensure continuous process improvement

• Monitor advancements in information privacy and security technologies to ensure organizational adaptation and compliance

• Assist with creating and updating IT security and compliance documentation

• Review and investigate security related cases, alerts and events

• Monitor and provide oversight of IT security tools and platforms

• H.S. Diploma or General Education Degree with at least 6 years of relevant work experience OR an Associate’s degree with at least 4 years of relevant work experience OR a Bachelor’s degree with at least 2 years of relevant work experience

• At least 2 years of experience in information security

• Superior organizational, prioritization, and time management skills

• Ability to maintain a high level of integrity and confidentiality

• Demonstrated problem-solving ability and analytical skills

• Ability to interact, listen, and communicate effectively, both written and verbal with all stakeholders

Preferred Qualifications

• Experience working in the pharmaceutical/biotechnology industry

• Experience in risk management

• Experience with managing change control processes

• SANS GSEC

• Root cause analysis skills

Job Location

This is a hybrid role in Silver Spring, MD, and reports onsite at least 2 days a week.

At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.

The salary for this position ranges from $91,000 to $125,000 per year. In addition, this role is eligible for the Company’s short-term and long-term incentive programs

The salary range is the range United Therapeutics Corporation in good faith believes is the range of possible compensation for this role at the time of this posting depending on the candidate’s experience, qualifications, geographic location, and other factors permitted by law. The Company may ultimately pay more or less than the posted range. This range may be modified in the future. No amount is considered to be wages or compensation until such amount is earned, vested, and determinable under the terms and conditions of the applicable policies and plans. The amount and availability of any bonus, commission, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company’s sole discretion unless and until paid and may be modified at the Company’s sole discretion, consistent with the law.

Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities

United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.

We strive to be an organization that engages the minds, hearts, and most spirited efforts of each of our employees. Our sense of purpose transforms what we do from work into mission, occupation into vocation and achievement into success.

We challenge our employees with innovative and revolutionary projects, offer an environment which fosters high-level job performance and provide a highly competitive total rewards package. This is what makes United Therapeutics a stimulating place to work.

We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.

United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension( PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).

The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option